Clinical Trials

Masimo (NASDAQ: MASI) announced the findings of a retrospective study published in the Journal of Clinical Monitoring and Computing in which Dr. Ayten Saracoglu and colleagues at...

Study aims to validate development of a novel combination product that links a drug to a smart phone app, enabling patients to personalise and...

Medtronic has announced final findings from a randomized, international, multi-center study that confirmed the effectiveness of the GI Genius™ intelligent endoscopy module, which uses AI...

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery...

The trial with VALVOSOFT® its disruptive, non-invasive, ultrasound treatment was proven to: be safe and feasibleprovide a sustained repair of the aortic valveimprove quality of life...

Royal Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first-line diagnostic ambulatory monitoring solution with post-cryptogenic stroke patients. The study...

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery...

An Artificial Intelligence (AI) programme created by Bering Limited and study conducted by iCAIRD, Scotland’s Industrial Centre for AI Research in Digital Diagnostics has...

GLEAMER, a French MedTech company pioneering the use of artificial intelligence technology in the practice of radiology, announced that the United States Food and...